-
Thematic Analysis
NewAdvertising Sector Scorecard, Q1 2024 Update – Thematic Intelligence
Advertising has been caught up in the artificial intelligence (AI) frenzy and will be one of the industries most disrupted by AI. Generative AI is reshaping advertisers’ practices through tailored, effective ads and dynamic campaigns that evolve according to consumer response. As a result, the relationship between technology, artists, and brands paying for campaigns will profoundly change over the coming years. There is a real concern that advertisers will divert their money into AI-generated art rather than paying artists and...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Posoleucel in Cytomegalovirus (HHV-5) Infections
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Posoleucel in Cytomegalovirus (HHV-5) Infections report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Posoleucel in Cytomegalovirus (HHV-5) Infections Drug Details: Posoleucel (ALVR-105) is under...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Posoleucel in Herpesviridae Infections
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Posoleucel in Herpesviridae Infections report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Posoleucel in Herpesviridae Infections Drug Details: Posoleucel (ALVR-105) is under development for...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Posoleucel in Epstein–Barr Virus (HHV-4) Infections
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Posoleucel in Epstein–Barr Virus (HHV-4) Infections report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Posoleucel in Epstein–Barr Virus (HHV-4) Infections Drug Details: Posoleucel (ALVR-105)...
-
Company Insights
J C Bamford Excavators Ltd. – Digital Transformation Strategies
JCB Digital Transformation Strategies Overview JC Bamford Excavators (JCB) has been focusing on forging technology partnerships and integrating digital technologies into its products to efficient operations and enhance customer experience. The annual ICT spending of JCB was estimated at $132.7 million in 2023. A major share of this spending is earmarked for acquiring ICT services, software, and hardware from vendors. JCB is a manufacturer and distributor of construction equipment. The company offers services such as sure price, service agreement, repair,...
-
Product Insights
Generalized Seizures – Drugs In Development, 2023
Global Markets Direct’s, ‘Generalized Seizures - Drugs In Development, 2023’, provides an overview of the Generalized Seizures pipeline landscape. The report provides comprehensive information on the therapeutics under development for Generalized Seizures, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Tonic-Clonic (Grand Mal) Seizure – Drugs In Development, 2023
Global Markets Direct’s, ‘Tonic-Clonic (Grand Mal) Seizure - Drugs In Development, 2023’, provides an overview of the Tonic-Clonic (Grand Mal) Seizure pipeline landscape. The report provides comprehensive information on the therapeutics under development for Tonic-Clonic (Grand Mal) Seizure, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press...
-
Product Insights
Seizures – Drugs In Development, 2023
Global Markets Direct’s, ‘Seizures - Drugs In Development, 2023’, provides an overview of the Seizures pipeline landscape. The report provides comprehensive information on the therapeutics under development for Seizures, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Autism Spectrum Disorder (ASD) – Drugs In Development, 2023
Global Markets Direct’s, ‘Autism Spectrum Disorder (ASD) - Drugs In Development, 2023’, provides an overview of the Autism Spectrum Disorder (ASD) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Autism Spectrum Disorder (ASD), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press...
-
Product Insights
Bienvenue Opencut Mine
The Bienvenue Opencut Mine is a nickel mine in New Caledonia. It is currently in operation. Empower your strategies with our Bienvenue Opencut Mine report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to buy...